Related Experiment Video
Updated: Sep 4, 2025

Intracoronary Acetylcholine Provocation Testing for Assessment of Coronary Vasomotor Disorders
Published on: August 18, 2016
Apixaban-Induced Pseudo-Ludwig's Angina
Nicholas Figaro1, Keegan Figaro2, Rajeev V Seecheran3
1Otolaryngology, Eric Williams Medical Sciences Complex, Mt. Hope, TTO.
A rare case of pseudo-Ludwig's angina, caused by apixaban medication, was successfully treated. This condition mimics Ludwig's angina but has noninfectious origins, highlighting the importance of considering medication side effects.
Area of Science:
- Otolaryngology
- Emergency Medicine
- Pharmacology
Background:
- Ludwig's angina is a severe bacterial infection of the floor of the mouth.
- Pseudo-Ludwig's angina involves noninfectious sublingual swelling, often mimicking the original condition.
- Sublingual hematomas from anticoagulants like warfarin are rarely reported.
Observation:
- A case of pseudo-Ludwig's angina was observed.
- The patient's condition was induced by apixaban, a novel anticoagulant.
- The presentation mimicked the severe airway compromise seen in Ludwig's angina.
Findings:
- Apixaban was identified as the causative agent for the pseudo-Ludwig's angina.
- Urgent surgical intervention was required for management.
- Supportive care included antibiotics and glucocorticoids.
Implications:
- This case expands the differential diagnosis for acute upper airway obstruction.
- It highlights the potential for apixaban to cause significant bleeding complications, including sublingual hematoma.
- Early recognition and prompt management are crucial for favorable outcomes in pseudo-Ludwig's angina.
More Related Videos
Related Concept Videos
Angina II: Classification
Angina III: Clinical Manifestations and Assessment
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Angina IV: Management
Peripheral Artery Disease I: Introduction

